[EN] TOCOTRIENOL DERIVATIVES AND ASSOCIATED METHODS<br/>[FR] DÉRIVÉS DE TOCOTRIÉNOL ET MÉTHODES ASSOCIÉES
申请人:FIRST TECH INTERNAT LTD
公开号:WO2013082570A1
公开(公告)日:2013-06-06
Compositions of matter including (R)-2,5,6,8-tetramethyl-8-((3E,7E)-4,8,12- trimethyltrideca-3,7, 1 1 -trienyl)- 1,2,3,8,9, 10-hexahydrochromeno[5,6- e][l,3]oxazine and (R)-2,6,8-trimethyl-8-((3E,7E)-4,8,12-trimethyltrideca-3,7, 11- trienyl)-1,2,3,8,9, 10-hexahydrochromeno[5,6-e][1,3]oxazine are disclosed herein. Further disclosed are methods of preparation of such compounds and the use of such compounds as anticancer agents.
本文披露了包括(R)-2,5,6,8-四甲基-8-((3E,7E)-4,8,12-三甲基十三碳-3,7,11-三烯基)-1,2,3,8,9,10-六氢-咔啉[5,6-e][1,3]噁唑和(R)-2,6,8-三甲基-8-((3E,7E)-4,8,12-三甲基十三碳-3,7,11-三烯基)-1,2,3,8,9,10-六氢-咔啉[5,6-e][1,3]噁唑等物质的组合物。此外,还披露了制备这些化合物的方法以及将这些化合物用作抗癌剂的用途。